Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC

NCT03716388 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis Chronic Mild
Ulcerative Colitis Chronic Moderate

Interventions

BIOLOGICAL: Fecal Microbiota Transplantation
DRUG: Mesalamine Granules
OTHER: Placebo infusion
OTHER: Placebo granules

Sponsor

Dayanand Medical College and Hospital

Collaborators

[object Object]